Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Raises $28M Private Equity Financing

Premium

S

AN DIEGO--Illumina, a two-year-old company that develops single-nucleotide polymorphism analysis technologies, completed a $28 million private equity financing round last week. New investors included the Tisch Family Fund, Lombard Odier & Cie, State Farm Automobile Insurance, Chase Capital Partners, PE, Dow Chemical, and Chevron Technology Ventures. Existing investors--Venrock Associates, Arch Venture Partners, CW Group, and Tredegar Investments--also participated.

Filed under